Botulinum toxin type-A in the management of spastic equinovarus deformity after stroke: Comparison of 2 injection techniques

Article Figures & Data

Download figure
Open in new tab
Download powerpoint
Figure 1
Illustration of the injection sites of the gastrocnemius muscle with an alternative injection technique. Group I: Two injection sites. Group II: Four injection sites.

Table 1

Comparison of spastic equinovarus deformity patients’ characteristics in Group I (2 injection sites) and Group II (4 injection sites).

Variable	Group I Mean ± SD (95% CI)	Group II Mean ± SD (95% CI)	P	Mean difference (95% CI)
No	12	14
Age (years)	51 ± 8 (45.9-56.1)	50 ± 8 (45.4-54.6)	0.75	1 (-5.5-7.5)
Onset (months)	6.3 ± 2.3 (4.8-7.8)	6.2 ± 2.3 (4.9-7.5)	0.91	0.10 (-1.8-1.9)
M0 (sec)	34 ± 8.6 (28.3-39.7)	36 ±12 (29.1-42.9)	0.64	-2 (-10.7-6.7)
M1 (sec)	23 ± 6 (19.2-26.8)	24 ± 9 (18.8-29.2)	0.75	-1 (-7.3-5.3)
M3 (sec)	22 ± 7 (17.6-26.5)	24 ± 8 (19.4-28.6)	0.51	-2 (-8.1-4.1)
M6 (sec)	25 ± 7 (20.6-29.5)	26 ± 9 (20.8-31.2)	0.76	-1 (-7.6-5.6)